Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt
· Delayed Price · Currency is EGP 84.50
+1.51 (1.82%)
At close: Apr 28, 2026
EGX:PHAR Balance Sheet
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1,433 | 1,295 | 675.8 | 482.97 | 311.59 | Upgrade
|
| Cash & Short-Term Investments | 1,433 | 1,295 | 675.8 | 482.97 | 311.59 | Upgrade
|
| Cash Growth | 10.66% | 91.68% | 39.93% | 55.00% | -57.48% | Upgrade
|
| Accounts Receivable | 3,325 | 1,331 | 1,153 | 946.58 | 792.04 | Upgrade
|
| Other Receivables | 356.79 | - | 0.67 | 12.7 | 10.95 | Upgrade
|
| Receivables | 3,682 | 3,049 | 2,359 | 1,807 | 1,172 | Upgrade
|
| Inventory | 3,887 | 3,585 | 2,242 | 2,162 | 1,818 | Upgrade
|
| Other Current Assets | 12.33 | 197.91 | 209.39 | 130.2 | 234.32 | Upgrade
|
| Total Current Assets | 9,015 | 8,127 | 5,486 | 4,582 | 3,536 | Upgrade
|
| Property, Plant & Equipment | 8,205 | 6,748 | 4,024 | 1,838 | 1,372 | Upgrade
|
| Long-Term Investments | 675.87 | 465.26 | 466.49 | 352.34 | 326.84 | Upgrade
|
| Other Intangible Assets | 40.14 | 32.05 | 2.3 | 1.57 | - | Upgrade
|
| Long-Term Deferred Tax Assets | 337.61 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | -0 | - | - | Upgrade
|
| Total Assets | 18,273 | 15,373 | 9,979 | 6,774 | 5,235 | Upgrade
|
| Accounts Payable | 780.42 | 381.8 | 138.42 | 185.56 | 60.37 | Upgrade
|
| Accrued Expenses | - | 184.12 | 100.83 | 88.48 | 63.29 | Upgrade
|
| Short-Term Debt | 5,027 | 4,435 | 2,083 | 2,047 | 1,234 | Upgrade
|
| Current Portion of Leases | 0.38 | 0.3 | 2.19 | 1.39 | - | Upgrade
|
| Current Income Taxes Payable | 388.95 | 344.85 | 184.98 | 106.82 | 110.62 | Upgrade
|
| Other Current Liabilities | 1,583 | 540.15 | 321.05 | 230.07 | 192 | Upgrade
|
| Total Current Liabilities | 7,780 | 5,887 | 2,831 | 2,660 | 1,661 | Upgrade
|
| Long-Term Debt | 3,759 | 4,782 | 2,832 | 812.13 | 529.07 | Upgrade
|
| Long-Term Leases | 11.98 | 10.71 | 0.13 | 0.79 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 190.77 | 35.83 | 54.79 | 58.94 | 71.84 | Upgrade
|
| Total Liabilities | 11,741 | 10,715 | 5,718 | 3,532 | 2,261 | Upgrade
|
| Common Stock | 1,688 | 1,488 | 1,488 | 991.71 | 991.71 | Upgrade
|
| Retained Earnings | 1,834 | 1,904 | 1,508 | 1,286 | 1,047 | Upgrade
|
| Comprehensive Income & Other | 2,722 | 1,262 | 1,262 | 961.82 | 931.82 | Upgrade
|
| Total Common Equity | 6,243 | 4,654 | 4,257 | 3,239 | 2,971 | Upgrade
|
| Minority Interest | 288.7 | 3.82 | 3.39 | 3.05 | 2.82 | Upgrade
|
| Shareholders' Equity | 6,532 | 4,658 | 4,261 | 3,242 | 2,973 | Upgrade
|
| Total Liabilities & Equity | 18,273 | 15,373 | 9,979 | 6,774 | 5,235 | Upgrade
|
| Total Debt | 8,798 | 9,229 | 4,918 | 2,862 | 1,763 | Upgrade
|
| Net Cash (Debt) | -7,364 | -7,933 | -4,242 | -2,379 | -1,452 | Upgrade
|
| Net Cash Per Share | -45.41 | -53.33 | -28.52 | -23.99 | -14.64 | Upgrade
|
| Filing Date Shares Outstanding | - | 148.76 | 148.76 | 99.17 | 99.17 | Upgrade
|
| Total Common Shares Outstanding | - | 148.76 | 148.76 | 99.17 | 99.17 | Upgrade
|
| Working Capital | 1,235 | 2,241 | 2,655 | 1,922 | 1,876 | Upgrade
|
| Book Value Per Share | - | 31.28 | 28.62 | 32.66 | 29.95 | Upgrade
|
| Tangible Book Value | 6,203 | 4,622 | 4,255 | 3,238 | 2,971 | Upgrade
|
| Tangible Book Value Per Share | - | 31.07 | 28.60 | 32.65 | 29.95 | Upgrade
|
| Land | - | 83.19 | 83.19 | 83.19 | - | Upgrade
|
| Buildings | - | 543.43 | 542.86 | 543.84 | - | Upgrade
|
| Machinery | - | 2,158 | 1,983 | 1,892 | - | Upgrade
|
| Construction In Progress | - | 5,694 | 3,058 | 866.16 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.